API
VRTX icon

Advisor Partners II’s Vertex Pharmaceuticals VRTX Stock Holding History

Advisor Partners II’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$5.47M Sell
15,732
-36
-0.2% -$12.6K 0.22% 76
2023
Q2 		$5.55M Buy
15,768
+1,562
+11% +$526K 0.26% 66
2023
Q1 		$4.48M Buy
14,206
+1,887
+15% +$566K 0.25% 80
2022
Q4 		$3.56M Buy
12,319
+1,486
+14% +$453K 0.22% 92
2022
Q3 		$3.14M Buy
+10,833
New +$3.12M 0.24% 84

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisor Partners II's VRTX Position: Q3 2023 in Review

Advisor Partners II reduced its Vertex Pharmaceuticals (VRTX) stake by 0.23% in Q3 2023, selling an estimated $12.6K and leaving 15,732 shares worth $5.47M. The position accounts for 0.22% of the portfolio, ranked #76.

Advisor Partners II first reported a position in VRTX in Q3 2022 and has held it in 5 quarters since. The position peaked at $5.55M in Q2 2023. 1,277 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.

  • Advisor Partners II held 15,732 shares of Vertex Pharmaceuticals worth $5.47M as of Q3 2023.
  • Advisor Partners II sold 36 Vertex Pharmaceuticals shares in Q3 2023, an estimated $12.6K.
  • Vertex Pharmaceuticals made up 0.22% of Advisor Partners II's portfolio in Q3 2023, its #76 holding.
  • Advisor Partners II first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 5 quarters since.
  • Advisor Partners II's Vertex Pharmaceuticals position peaked at $5.55M in Q2 2023.
  • 1,277 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.